Erythropoietin in Renal Failure: Blood Rheology and 2,3-DPG Levels.
Abstract
Previous studies have documented that a substantial population of anemic patients on long term hemodialysis (LTh)) are transfusion dependent (4). ThIs anemia can be corrected by the administration of recombinant human erythropoietin, (rHU-EPO) (2,7,20). However, exacerbation of hypertension and an increased tendency to clot vascular access sites have been observed by the Canadian erythropoietin study group (2) in rHU-EPO treated patients.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 23, 1992
- Accession Number
- ADA360149
Entities
People
- C. R. Valeri
- Jaclyn B. Metzger
- James P. Crowley
- Joseph A. Chazan
- Lucille Pono
Organizations
- Boston University